glp-1 diabetes news A wave of new #GLP1 drug options for type 2 #Diabetes and #Obesity was a major focus at #ADA2026. In the latest JAMA Medical podcast, Jennifer Abbasi interviews Rita Kalyani, MD If you are taking a

Market-Based Data Collection In order to support the development of a relative market-based payment methodology under the IPPS, we proposed to collect market-based payment rate data on the Medicare cost report for cost reporting periods ending on or after January 1, 2026

Pathology of hereditary breast cancer

GLP-1 RAs have many beneficial effects beyond glycemic control, including a protective role on the cardiovascular system

Managing the GLP-1 Plateau Some patients find that after several months on a GLP-1 medication, their weight loss stalls even at the maximum dosage

This side effect sparked the idea that melanocortin peptides might enhance sexual function

GLP-1 medications can make a difference by supporting appetite control, stabilizing blood sugar, and helping your body respond more effectively to routine lifestyle changes